Both in Pharmaceuticals
Immunome vs Zymeworks
Over the past year IMNM returned +15.2% and ZYME returned +53.5%; their daily moves had a correlation of 0.41.
IMNM +15.2% ZYME +53.5%Growth of $1, one year, split-adjusted
| Metric | IMNM | ZYME |
|---|---|---|
| Price | $19.59 | $28.99 |
| Market cap | $2.31B | $2.08B |
| Today | +7.58% | +1.33% |
| 1 month | −6.3% | +15.3% |
| 6 months | −16.0% | +8.3% |
| Year to date | −8.8% | +10.1% |
| 1 year | +22.6% | +51.6% |
| Revenue growth (YoY) | −100.0% | −90.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −980.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 56.1× |
| Net cash | $520.0M | $270.7M |
| Dividend yield | — | — |
| Volatility (60d) | 57.6% | 46.5% |
| Short % of float | 17.1% | 13.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).